For breast cancer, and clinical trials start of a heavy particle beam therapy, which aims to cure without cutting.

This month, for breast cancer, National Institute of Radiological Sciences (Chiba) to start clinical trials of heavy ion therapy, which aims to cure without cutting.
Breast cancer treatment of conventional, a common combination of radiation-drug therapy and surgery, and one that can not be operative for "chronic disease, and those who do not want the surgery, the institute treatment options burden to a body is less you have a world of possibilities that it can "there.
Heavy particle beam, a special radiation that is to focus the powerful energy to cancer. According to the institute, facilities for the treatment currently only six facilities in the world. There in Japan 3 facility, it is used bone and soft tissue tumors, lung cancer, liver cancer, and prostate cancer, aim at the cure of breast cancer for the first time.
Due to the recent years, brace to secure the breast soft and the research report that shows the effectiveness of radiation therapy targeted irradiation range in Europe and the United States has increased, the irradiation position to cancer to prevent displacement has been developed, and breast cancer application to have been planned.

You will go into a closer look, such as side effects and efficacy through clinical trials, but I want to accelerate the speed of research for practical use early.


放射線医学総合研究所（千葉市）は今月、乳がんに対し、切らずに完治を目指す重粒子線治療の臨床試験を始める。
　従来の乳がん治療は、手術と放射線・薬物治療の併用が一般的だが、同研究所は「持病のために手術できない人や、手術を望まない人などに、体への負担が少ない治療の選択肢が広がる可能性がある」としている。
　重粒子線は、がんに強力なエネルギーを集中させられる特殊な放射線。同研究所によると、現在治療を行う施設は世界で６施設だけ。うち３施設が日本にあり、骨軟部腫瘍、肺がん、肝臓がん、前立腺がんなどに用いられているが、乳がんの完治を狙うのは初めてという。
　近年、欧米で照射範囲を絞った放射線治療の有効性を示す研究報告が増えたことや、がんへの照射位置がずれないように柔らかい乳房を固定する装具が開発されたことなどにより、乳がんへの応用が計画された。
　臨床試験を通じて有効性や副作用などの詳しく調べられていくでしょうが早期の実用化に向けて研究のスピードを早めて欲しいですね。